Abstract:Objectives This survey seeks the opinion of UK community pharmacists to identify barriers in the public health role of community pharmacists. Methods This study took the form of a descriptive, cross-sectional survey that generated mostly quantitative data. Questionnaires were mailed to 524 randomly selected community pharmacists from Barnet, London and its surrounding areas, Bedfordshire, Cardiff and Edinburgh. All statistical analyses including tests for significance and correlation of variables were performe… Show more
“…As have also been identified in previous studies, inadequate funding for public health services remains a huge challenge for community pharmacy practice. This point was also highlighted by one of the GP participants, when he raised the issue of lack of time for pharmacists,…”
Section: Resultssupporting
confidence: 59%
“…A UK study identifies that the main roles provided by community pharmacists in public health were in the areas of smoking cessation services; infection control and prevention; promoting cardiovascular health and blood pressure control; provision of emergency hormonal contraception; prevention and management of drug abuse, misuse and addiction; and healthy eating and lifestyle advice. These findings to a large extent confirmed the findings of other UK studies . In a recent white paper, ‘Five year forward view’, the government presented its plan to make greater use of pharmacists through its plan for ‘Multispecialty Community Providers’ (MCPs), which would become the focal point for a far wider range of care needed by their registered patients .…”
Objectives
Using qualitative methods (interviews), this study aimed to identify barriers in the public health role of UK community pharmacists.
Methods
Data were collected through telephone interviews using Skype and recorded using ‘HD Call Recorder for Skype’. The qualitative data software package NVivo (version 10) was used for storage, retrieval and analysis of data.
Key findings
This study identified a number of barriers hindering the public health role of community pharmacists in the UK. The most frequently cited barriers included: challenges as to the use of new technologies and social media; lack of awareness; pharmacists’ lack of confidence in their public health role; commercial pressure from pharmacy owners; lack of time; inadequate funding; government policy on the public health role of pharmacists; inadequate communication skills; lack of integration of UK undergraduate healthcare programmes; logistics; as well as the fact that UK pharmacists qualify as scientists rather than as clinicians.
Conclusions
Many of the barriers identified in this study have also been confirmed in other studies. A clearer policy by the government on the public health role of pharmacists, supported by Schools of Pharmacy and relevant stakeholders might be a way forward.
“…As have also been identified in previous studies, inadequate funding for public health services remains a huge challenge for community pharmacy practice. This point was also highlighted by one of the GP participants, when he raised the issue of lack of time for pharmacists,…”
Section: Resultssupporting
confidence: 59%
“…A UK study identifies that the main roles provided by community pharmacists in public health were in the areas of smoking cessation services; infection control and prevention; promoting cardiovascular health and blood pressure control; provision of emergency hormonal contraception; prevention and management of drug abuse, misuse and addiction; and healthy eating and lifestyle advice. These findings to a large extent confirmed the findings of other UK studies . In a recent white paper, ‘Five year forward view’, the government presented its plan to make greater use of pharmacists through its plan for ‘Multispecialty Community Providers’ (MCPs), which would become the focal point for a far wider range of care needed by their registered patients .…”
Objectives
Using qualitative methods (interviews), this study aimed to identify barriers in the public health role of UK community pharmacists.
Methods
Data were collected through telephone interviews using Skype and recorded using ‘HD Call Recorder for Skype’. The qualitative data software package NVivo (version 10) was used for storage, retrieval and analysis of data.
Key findings
This study identified a number of barriers hindering the public health role of community pharmacists in the UK. The most frequently cited barriers included: challenges as to the use of new technologies and social media; lack of awareness; pharmacists’ lack of confidence in their public health role; commercial pressure from pharmacy owners; lack of time; inadequate funding; government policy on the public health role of pharmacists; inadequate communication skills; lack of integration of UK undergraduate healthcare programmes; logistics; as well as the fact that UK pharmacists qualify as scientists rather than as clinicians.
Conclusions
Many of the barriers identified in this study have also been confirmed in other studies. A clearer policy by the government on the public health role of pharmacists, supported by Schools of Pharmacy and relevant stakeholders might be a way forward.
“…Despite both pharmacists and GPs acknowledging the importance of collaboration to optimise the provision of extended services, they commonly perceived collaboration to be poor. This perception was influenced by GPs’ negative attitudes towards pharmacists (Agomo, Ogunleye, & Portlock, 2016b; Campion et al., ; Evans et al., ; George et al., 2006b; Latif et al., ; Urban et al., ; Wilcock & Harding, ), GPs being suspicious of pharmacists’ financial motives (Urban et al., ) and competition for services (Agomo et al., 2016b; Evans et al., ; Latif et al., ; Wilcock & Harding, ). Examples of poor engagement included lack of GP availability (Mackridge, Beynon, McVeigh, Whitfield, & Chandler, ; Savage et al., ), patient referrals (Latif et al., ; Lucas & Blenkinsopp, ; Pumtong et al., ) and feedback (Akram et al., ; Urban et al., ).…”
Section: Resultsmentioning
confidence: 99%
“…Lack of publicity for extended services and roles was commonly cited both by pharmacists and GPs. Some pharmacists perceived promotion to be a governmental duty (Agomo et al., 2016b, ; Dewsbury, Rodgers, & Krska, ) with recommendations through public health campaigns and advertising (Agomo et al., 2016b; Horsfield et al., ; Urban et al., ). In one study, pharmacists perceived recommendations by other healthcare professionals, other pharmacists and patients to be the most effective means of raising awareness for medicine‐related services (Gammie, Rodgers, Loo, Corlett, & Krska, ).…”
Section: Resultsmentioning
confidence: 99%
“…Despite both pharmacists and GPs acknowledging the importance of collaboration to optimise the provision of extended services, they commonly perceived collaboration to be poor. This perception was influenced by GPs' negative attitudes towards pharmacists (Agomo, Ogunleye, & Portlock, 2016b;Campion et al, 2007;Evans et al, 2016;George et al, 2006b;Latif et al, 2016;Urban et al, 2008;Wilcock & Harding, 2008), GPs being suspicious of pharmacists' financial motives (Urban et al, 2008) & Harding, 2008). Examples of poor engagement included lack of GP availability (Mackridge, Beynon, McVeigh, Whitfield, & Chandler, 2010;Savage et al, 2013), patient referrals (Latif et al, 2016;Lucas & Blenkinsopp, 2015;Pumtong et al, 2008) and feedback (Akram et al, 2012;Urban et al, 2008).…”
Section: Collaboration With General Practitionersmentioning
There has been a strong policy emphasis over the past decade on optimising patient-centred care and reducing general practitioners' (GPs') workload by extending community pharmacy services and collaboration between pharmacists and GPs. Our aim was to review current evidence of pharmacists' and GPs' views of extended community pharmacy services and pharmacists' roles in the United Kingdom (UK). A systematic review was undertaken looking at UK studies investigating pharmacists' and/or GPs' views of community pharmacy services or roles from 2005 to 2017. A range of databases were searched including EMBASE, PubMed, Scopus, Web of Science, International Pharmaceutical Abstracts (IPA), PsycINFO, Science Direct and The Cumulative Index to Nursing and Allied Health Literature (CINAHL). In addition, reference lists of included studies were screened and grey literature was searched. Following the application of inclusion/exclusion criteria, the quality of papers was critically analysed, findings were extracted into a grid and subjected to narrative synthesis following thematic analysis. The search strategy yielded a total of 4,066 unique papers from which 60 were included. Forty-seven papers covered pharmacists' views, nine combined both pharmacists' and GPs' views and four covered GPs' views. Study designs included interviews (n = 31, 52%), questionnaire surveys (n = 17, 28%) and focus groups (n = 7, 12%). Three main themes emerged from the data: "attitudes towards services/roles", "community pharmacy organisations" and "external influences". Pharmacists and GPs perceived a number of barriers to successful implementation and integration of pharmacy services. Moreover, collaboration between pharmacists and GPs remains poor despite the introduction of extended services. Overall, extending community pharmacy services require quality-driven incentives and joint working between community pharmacists and GPs to achieve better integration within the patient's primary care pathway.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.